ELAB — PMGC Holdings Share News
0.000.00%
Last trade - 00:00- $7.00m
- -$2.36m
- $0.59m
Elevai Labs sinks after announcement of reverse stock split
Brief: PMGC Holdings Announces Reverse Stock Split To Maintain Nasdaq Listing Compliance
Brief: Pmgc Holdings Inc And Inmune Bio Terminate License Agreement
Factbox: Fat, not muscle: drugmakers in race for next weight-loss breakthrough
Brief: Northstrive Biosciences, Subsidiary of PMGC Holdings, Reports Positive Updates for Obesity Drug Candidates Targeting Fat Loss and Muscle Preservation used in Combination with GLP-1
Brief: PMGC Capital Builds Portfolio with Acquisition Of US Focused Uranium Energy & Fire Prevention Tech Co's
Brief: Pmgc Holdings Elevai Biosciences Terminates CEO Jordan Plews
Brief: Carmell To Acquire Elevai Skincare
U.S. STOCKS ON THE MOVE-AMC, Alnylam, Super Micro
U.S. STOCKS ON THE MOVE-Replimune, Snowflake, Virpax Pharmaceuticals
U.S. STOCKS ON THE MOVE-Snowflake, GE Vernova, EQT Corp
Elevai Labs falls after announcing 1-for-200 stock split
Brief: Elevai Labs Announces Reverse Stock Split To Maintain Nasdaq Listing Compliance
Brief: Elevai Labs Inc To Implement 1-For-200 Reverse Stock Split
Brief: Elevai Labs Inc. Announces Withdrawal Of Offer To Exchange And Plans To Reassess
Brief: Elevai Labs says Nasdaq Grants Co Exception To Cure Bid Price Deficiency
Brief: Elevai Labs Inc. Announces Update And Extension Of Pending Offer To Exchange
Brief: Elevai Biosciences highlights Past Positive Preclinical Data Showing Potential Of El-32, A Dual Myostatin & Activin-A Blocker, For The Treatment Of Obesity
Brief: L1 Capital Global Opportunities Master Fund Reports 9.99% Passive Stake In Elevai Labs